Le Lézard
Classified in: Health
Subject: PDT

Ultrasound Research Group at Neurotechnology Introduces Ultrasonic Array Controller for Ultrasonic Particle Manipulation


VILNIUS, Lithuania, Oct. 17, 2018 /PRNewswire/ -- The Ultrasound Research Group (URG) at Neurotechnology today announced the launch of its new Ultrasonic Array Controller UAC128, a continuous-wave FPGA-based controller for driving ultrasonic transducer arrays. The controller, together with a transducer array, can be used for ultrasonic field focusing, beam forming and other ultrasonic field control for ultrasonic particle manipulation research and applications such as cell trapping, patterning and sorting, patterning and assembly of micro components and materials. The controller can also be applied in ultrasonic haptic feedback and ultrasonic wireless power transfer systems.

The Ultrasonic Array Controller UAC128 features:

"Initially, we had to design and build most of the equipment for our research in the field of ultrasonic particle manipulation ourselves, due to the lack of commercially available equipment and its extremely high cost," said Dr. Osvaldas Putkis, project lead for Neurotechnology's Ultrasound Research Group. "So we decided to introduce our own more cost-effective ultrasonic array controller, designed primarily for ultrasonic particle manipulation research and applications."

Ultrasonic Levitator/Manipulator

The URG has also released Levitator Model D, an ultrasonic levitator/manipulator that can be driven with the Ultrasonic Array Controller UAC128 and used for demonstration and visualization of ultrasonic particle manipulation.

VIDEO: Levitator Model D in action

Levitator Model D is most suited for levitation and manipulation of expanded polystyrene (EPS) particles, however levitation of heavier particles, such as water droplets, is also possible.

Both the Ultrasonic Array Controller UAC128 and Levitator Model D are available now from Neurotechnology's URG. The URG can also custom design and build levitators/manipulators to meet a range of specific applications. Contact the URG.

About Neurotechnology

Neurotechnology is a developer of high-precision algorithms and software based on deep neural networks and other AI-related technologies. The company was started in 1990 in Vilnius, Lithuania, with the key idea of using neural networks for various applications, such as biometric person identification, computer vision, robotics, and artificial intelligence. Since the first release of its fingerprint identification system in 1991, the company has delivered more than 200 products and version upgrades. More than 3,000 system integrators, security companies and hardware providers in over 140 countries integrate Neurotechnology's algorithms into their products. The company's algorithms have achieved top results in independent technology evaluations, including NIST MINEX and IREX.

To meet the demands of a variety of applications, Neurotechnology has developed many advanced algorithms based on deep learning and computer vision as well. The company's Ultrasound Research Group (URG) also undertakes research in the fields of ultrasonic particle manipulation, parametric array and transducer technology and develops novel algorithms, hardware and electronics solutions for ultrasonic applications.

CONTACT:
Amy Hunter
503-927-5872
[email protected]

SOURCE Neurotechnology


These press releases may also interest you

at 07:15
Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, is pleased to announce...

at 07:15
AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs). The acquisition marks a major step forward in AstraZeneca...

at 07:15
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as "Dr. Reddy's"), a global pharmaceutical company, announced the launch of Versavo® (bevacizumab) in the United Kingdom (UK). Dr. Reddy's...

at 07:11
TrustCommerce, a Sphere company and leading provider of end-to-end integrated healthcare payments and security software, today announced that its Cloud Payments platform is now integrated with the Practice Fusion electronic health records (EHR), a...

at 07:10
Tilak Healthcare, a leading company in digital health for the monitoring of chronic eye diseases, announces the appointment of three experts to support the leadership team, currently composed of Edouard Gasser (CEO & co-founder), Philip Bouchet...

at 07:10
Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced its financial results...



News published on and distributed by: